SAN FRANCISCO--(BUSINESS WIRE)--Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application ...
BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...
Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.
Bioreactors have become irreplaceable tools in bioprocessing, revolutionizing the production of many biotechnological products. 1,2 They offer optimized and controlled environments to enhance cell ...
The MarketWatch News Department was not involved in the creation of this content. THE WOODLANDS, Texas, Dec. 2, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development ...
An updated bioreactor based on rocking technology has more advanced controls but is easier for biopharmaceutical manufacturers to use. Single-use bioreactors come in all shapes and sizes that fit the ...
SOURCE WuXi PharmaTech (Cayman) Inc. SHANGHAI and TAIPEI, Oct. 30, 2013 - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing ...
CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing ...
The addition of the 50-liter single-use bioreactor significantly expands Cellipont's cGMP-compliant capacity, enabling clients to seamlessly transition from early development to large-scale, ...
The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in the pursuit of bioreactor process optimization. SAN ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results